Unique ID issued by UMIN | C000000238 |
---|---|
Receipt number | R000000299 |
Scientific Title | OmX: Peritoneal dilaysis treatment once daily for chronic renal failure -Clinically controlled trial using icodextrin and dextrose solution. |
Date of disclosure of the study information | 2007/12/31 |
Last modified on | 2005/09/14 23:06:11 |
OmX: Peritoneal dilaysis treatment once daily for chronic renal failure -Clinically controlled trial using icodextrin and dextrose solution.
OmX
OmX: Peritoneal dilaysis treatment once daily for chronic renal failure -Clinically controlled trial using icodextrin and dextrose solution.
OmX
Japan |
chronic renal failure
Nephrology |
Others
NO
To determine whether once daily treatment using post-marketing peritoneal dialysis solutions- dianeal and extraneal- on patients with chronic renal failure requiring dialysis treatment is beneficial or not.
Because the load on the patient in once daily peritoneal dialysis treatment is less and it contributes to a dramatic reuction in medical costs, by clarifying which peritoneal dialysis solution should be chosen and possibilities for this treatment method, it will be possible to obtain beneficial and safe guidelines for this treatment. This trial was therefore deemed necessary and thus planned.
Efficacy
Confirmatory
Pragmatic
Not applicable
Renal creatinine clearance
Technical survival (period until use of another dialysis solution)
Renal creatinine clearance variation rate
99mTcDTPA-GFR
QOL and SGA
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
Numbered container method
2
Treatment
Medicine |
Group using icodextrin, will commence with one 2L bag/day. Additional bags will be added in order to maintain the renal function value at the start date.
Group using dextrose solution, will commence with one 2L bag/day. Additional bags will be added in order to maintain the renal function value at the start date.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1.Chronic renal failure requiring dialysis treatment. Creatinine clearance less than or equal to 10mL/min.
2. Patients aged between 20-80 years at the time of obtaining consent
3. Patients who provide their written consent of their own free will after receiving and fully comprehending a detailed explanation concerning participation in the trial
1.Schizophrenia
2.Alzheimer's disease
3.Multiple cerebral infarction, dementia
4.Women who are pregnant or may become pregnant
5.Other patients that the doctor in charge of the trial (assistant doctor) judges to be unsuitable, such as conditions that require emergencey treatment such as cardiac insufficiency and pulmonary congestion.
40
1st name | |
Middle name | |
Last name | Renjiro Kuriyama |
Ohme Municipal General Hospital
Medical Nephrology
Higashi-ohme 4-16-5 Ohme Tokyo 198-0042
0428223191
1st name | |
Middle name | |
Last name | Renjiro Kuriyama |
Ohme Municipal General Hospital
Medical Nephrology
Higashi-ohme 4-16-5 Ohme Tokyo
0428-22-3191
kuriyama-npr@umin.ac.jp
Ohme Municipal General Hospital
Medical Nephrology, Ohme Municipal General Hospital
Self funding
NO
2007 | Year | 12 | Month | 31 | Day |
Unpublished
2005 | Year | 04 | Month | 01 | Day |
2005 | Year | 06 | Month | 01 | Day |
2007 | Year | 06 | Month | 01 | Day |
2007 | Year | 07 | Month | 01 | Day |
2007 | Year | 07 | Month | 01 | Day |
2007 | Year | 09 | Month | 01 | Day |
2005 | Year | 09 | Month | 14 | Day |
2005 | Year | 09 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000299
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |